Related Experiment Video
Updated: Jan 24, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
Published on: April 19, 2024
Cystic fibrosis year in review 2018, part 2
Adrienne P Savant1,2,3, Susanna A McColley1,2,3
1Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Insights
In 2018, research on cystic fibrosis (CF) highlighted its widespread effects and exacerbations. Studies also explored new therapies and patient-reported outcomes beyond CFTR modulator treatments.
Area of Science:
- Pulmonology
- Genetics
- Clinical Medicine
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting multiple organ systems.
- 2018 saw significant research output concerning CF's complexities.
Purpose of the Study:
- To summarize key 2018 publications on cystic fibrosis.
- To cover multisystem effects, pulmonary exacerbations, novel therapies, and patient-reported outcomes.
Main Methods:
- Literature review of 2018 publications.
- Categorization of studies based on research focus.
Main Results:
- Publications detailed the multisystemic impact of CF.
- Research addressed pulmonary exacerbations and emerging therapeutic strategies.
- Patient-reported priorities and outcomes were a significant focus.
Conclusions:
- 2018 research provided a comprehensive overview of CF.
- Understanding CF requires a focus on systemic effects, exacerbations, diverse therapies, and patient perspectives.
Abstract:
Cystic fibrosis (CF) research and case reports were robust in the year 2018. This report summarizes publications related the multisystem effects of CF, pulmonary exacerbations, new and expanded therapies other than cystic fibrosis transmembrane conductance regulator modulator studies, and patient-reported priorities and outcomes.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
2° Amines to N-Nitrosamines: Reaction with NaNO2

